Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis.
- 2025-05
- Meta-Analysis · n = 1,797
- Complementary therapies in medicine 89
- Mostafa Norouzzadeh
- Minoo Hasan Rashedi
- Mohammad Hesam Azizi
- Farshad Teymoori
- Zohreh Maghsoomi
- Farzad Shidfar
- PubMed: 39870328
- DOI: 10.1016/j.ctim.2025.103135
- High evidence
- Clinical
HS dose-dependently reduced systolic and diastolic BP compared to placebo and other teas. Although no significant differences were found between HS and antihypertensive drugs, HS showed moderate credibility for therapeutic BP reduction (> 10 mmHg), especially in individuals over 50 years, in trials lasting over four weeks, and in those with a low risk of bias.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes